Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats

Kidney and Blood Pressure Research

Volumn 29, Issue 2, 2006, Pages 74-83

  Husková, Zuzana ^a   Kramer, Herbert J ^b   Thumová, Monika ^a   Vaňourková, Zdenka ^a   Bürgelová, Marcela ^a   Teplan, Vladimír ^a   Malý, Jan ^a   Červenka, Luděk ^a,c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF BONN   (Germany)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

2K1C Goldblatt hypertensive rats; Anesthetized and conscious rats; ANG II infused rats; Hypertension; Plasma and kidney ANG II levels; Renin transgenic rats

Indexed keywords

ANESTHETIC AGENT; ANGIOTENSIN II; FUROSEMIDE; RENIN; THIOPENTAL;

ANESTHESIA; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; DECAPITATION; DRUG INFUSION; EXPERIMENTAL MODEL; HYPERTENSION; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM DEPLETION; TRANSGENIC ANIMAL;

ANESTHESIA; ANGIOTENSIN II; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DECAPITATION; HYPERTENSION; KIDNEY; MALE; RATS; RATS, INBRED DAHL; RATS, SPRAGUE-DAWLEY; RENIN; STRESS; STRESS, PHYSIOLOGICAL;

EID: 33747067676     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092981     Document Type: Article

References (52)

1. Mitchell KD, Navar LG: The renin-angiotensin-aldosterone system in volume control; in Baylis PH (ed): Bailliere's Clinical Endocrinology and Metabolism: Water and Salt Homeostasis in Health and Disease. London, Bailliere Tindall, 1989, vol 3, pp 393-430.
2. Hall JE, Brands MW: The renin-angiotensin-aldosterone system: renal mechanisms and circulatory homeostasis; in Seldin DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 1009-1046.
3. Navar LG, Nishiyama A: Why are angiotensin concentrations so high in the kidney? Curr Opin Nephrol Hypertens 2004;13:107-115.
4. Morton JJ, Wallace ECH: The importance of the renin-angiotensin system in the development and maintenance of hypertension in the two-kidney, one-clip hypertensive rat. Clin Sci 1983;64:359-370.
5. Ploth DW: Angiotensin-dependent renal mechanisms in two-kidney, one-clip renal vascular hypertension. Am J Physiol 1983;245:F131-F141.
6. Navar LG: The intrarenal renin-angiotensin system in hypertension. Kidney Int 2004;65:1522-1532.
7. Hall JE, Brands MW, Henegar JR: Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol 1999;10(suppl 11):S258-S265.
8. Navar LG, Harrison-Bernard LM: Intrarenal angiotensin II augmentation in angiotensin II dependent hypertension. Hypertens Res 2000;23:291-301.
9. Navar LG, Zou L, Von Thun A, Wang CT, Imig JD, Mitchell KD: Unraveling the mystery of Goldblatt hypertension. News Physiol Sci 1998;13:170-176.
10. 1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats. Hypertension 1999;33:102-107.
11. El-Dahr SS, Dipp S, Guan S, Navar LG: Renin, angiotensinogen, and kallikrein gene expression in two-kidney Goldblatt hypertensive rats. Am J Hypertens 1993;6:914-919.
12. Tokuyama H, Hayashi K, Matsuda H, Kubota E, Honda M, Okubo K, Takamatsu I, Tatematsu S, Ozawa Y, Wakino S, Saruta T: Differential regulation of elevated renal angiotensin II in chronic renal ischemia. Hypertension 2002;40:34-40.
13. Wang CT, Navar LG, Mitchell KD: Proximal tubular fluid angiotensin II levels in angiotensin II-induced hypertensive rats. J Hypertens 2003;21:353-360.
14. Sadjadi J, Puttaparthi K, Li L, Welborn MB, Rogers TE, Moe O, Clagett GP, Turnage RH, Levi M, Modrall JG: Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension. J Vasc Surg 2002;36:386-392.
15. Guan S, Fox, Mitchell KD, Navar LG: Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one-clip hypertensive rats. Hypertension 1992;20:763-767.
16. Von Thun AM, Vari RC, El-Dahr SS, Navar LG: Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol 1994;266:F120-F128.
17. 1 receptor blockade in hypertensive Ren-2 transgenic rats. J Hypertens 2004;22:819-825.
18. Kopkan L, Kramer HJ, Husková Z, Vaňourková Z, Škaroupková P, Thumová M, Červenka L: The role of intrarenal angiotensin II in the development of hypertension in Ren-2 transgenic rats. J Hypertens 2005;23:1531-1539.
19. Mitchell KD, Mullins JJ: ANG II dependence of tubuloglomerular feedback responsiveness in hypertensive ren-2 transgenic rats. Am J Physiol 1995;268:F821-F828.
20. 1 receptor blockade with candesartan. J Am Soc Nephrol 1999; 10(suppl 11):S197-S201.
21. 1 blockade in angiotensin II-induced hypertensive rats. J Am Soc Nephrol 1997;8:535-542.
22. 1 receptor blockade. J Am Soc Nephrol 1999;10(suppl 11):S266-S272.
23. Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harboring the mouse Ren-2 gene. Nature 1990;344:541-544.
24. Ingert C, Grima M, Coquard C, Barthelmebs M, Imbs JL: Effects of dietary salt changes on renal renin-angiotensin system in rats. Am J Physiol 2002;283:F995-F1002.
25. Fox J, Guan S, Hymel AA, Navar LG: Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am J Physiol 1992;262:F902-F909.
26. Nakamura S, Averill DB, Chappell MC, Diy DI, Brosnihan KB, Ferrario CM: Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR. Am J Physiol 2003;284:R164-R173.
27. Weber MA, Thornell IR, Stokes GS: Effect of hemorrhage with and without fluid replacement on plasma renin activity. Am J Physiol 1973;225:1161-1164.
28. Hodge RL, Lowe RD, Vane JR: The effects of alteration of blood volume on the concentration of circulating angiotensin in anesthetized dogs. J Physiol Lond 1966;185:613-626.
29. 1A receptors. Am J Physiol 1999;277:F303-F311.
30. Johnson MD, Malvin RL: Plasma renin activity during pentobarbital anesthesia and graded hemorrhage in dogs. Am J Physiol 1975;229:1098-1101.
31. Leenen FH, de Jong W, de Wied D: Renal venous and peripheral plasma renin activity in renal hypertension in the rat. Am J Physiol 1973;225:1513-1518.
32. Yun JC, Kelly GD, Bartter FC, Tate JE: Mechanisms for the increase in plasma renin activity by pentobarbital anesthesia. Life Sci 1978;22:1545-1554.
33. Pettinger WA, Tanaka K, Keeton K, Campbell WB, Brooks SN: Renin release, an artifact and its implications in rats. Proc Soc Exp Biol Med 1975;148:625-630.
34. Pettinger WA, Augusto L: Relevance of the rat as a laboratory model of human renin physiology. Clin Res 1971;19:544-546.
35. Pettinger WA, Marchelle M, Augusto L: Renin suppression by DOC and NaCl in the rat. Am J Physiol 1971;221:1071-1074.
36. Chapman BJ, Brooks DP, Munday KA: Half-life of angiotensin II in the conscious and barbiturate-anaesthetized rat. Br J Anaesth 1980;52:389-393.
37. Corman B, Barrault MB, Klingler C, Houot AM, Michel JB, Della Bruna R, Pinet F, Soubrier F: Renin gene expression in the aging kidney: effect of sodium restriction. Mech Ageing Dev 1995;84:1-13.
38. Cholewa BC, Meister CJ, Mattson DL: Importance of the renin-angiotensin system in the regulation of arterial blood pressure in conscious mice and rats. Acta Physiol Scand 2005; 183:309-320.
39. Rubattu S, Enea I, Ganten D, Salvatore D, Condorelli G, Condorelli G, Russo R, Romana M, gigante B, Trimarco B, Volpe M: Enhanced adrenal renin and aldosterone biosynthesis during sodium restriction in TGR(mRen2)27. Am J Physiol 1994;267:E515-E520.
40. DiBona GF: Physiology in perspective: the wisdom of the body. Neural control of the kidney. Am J Physiol 2005;289:R633-R641.
41. Ichihara A, Inscho EW, Imig JD, Mitchell KD: Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension. Hypertension 1997;29:442-449.
42. Grisk O, Rettig R: Interactions between the sympathetic nervous system and the kidneys in arterial hypertension. Cardiovasc Res 2004;61:238-246.
43. Yun JC, Donahue JJ, Bartter FC, Kelly GD: Effect of pentobarbital anesthesia and laparotomy on plasma renin activity in the dog. Can J Physiol Pharmacol 1979;57:412-416.
44. Červenka L, Kramer HJ, Malý J, Vaněč ková I, Bäcker A, Bokemeyer D, Bader M, Ganten D, Mitchell KD: Role of nNOS in regulation of renal function in hypertensive Ren-2 transgenic rats. Physiol Res 2002;51:571-581.
45. Wang CT, Chin SY, Navar LG: Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol 2000;279:F319-F325.
46. Van der Mark J, Kline RL: Altered pressure natriuresis in chronic angiotensin II hypertension in rats. Am J Physiol 1994;266:F739-F748.
47. Huang W-C, Ploth DW, Navar LG: Effects of saralasin infusion on bilateral renal function in two-kidney, one-clip Goldblatt hypertensive rats. Clin Sci 1982;62:573-579.
48. Huang W-C, Navar LG: Effects of unclipping and converting enzyme inhibition on bilateral renal function in Goldblatt hypertensive rats. Kidney Int 1983;23:816-822.
49. Bürgelová M, Kramer HJ, Teplan V, Thumová M, Červenka L: Effects of angiotensin-(1-7) blockade on renal function in rats with enhanced intrarenal ANG II activity. Kidney Int 2005;67:1453-1461.
50. Vaněčková I, Cahová M, Kramer HJ, Husková Z, Škaroupková P, Komers R, Červenka L: Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous Ren-2 transgenic rats. Kidney Blood Press Res 2004;27:203-210.
51. Vaněčková I, Škaroupková P, Dvořák P, Čertíková Chábová V, Tesař V, Bader M, Ganten D, Kramer HJ: Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats. Physiol Res 2005;54:17-24.
52. Carruba MO, Bondiolotti GF, Picotti GB, Catteruccia N, Da Prada M: Effects of diethyl ether, halothane, ketamine and urethane on sympathetic activity in the rat. Eur J Pharmacol 1987;134:15-24.